Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	-	ARHGAP42 ARHGAP26 KIF1B DOCK10 ARHGEF18 ARHGEF17 PLCE1	9.76e-04	391	75	7	2.30.29.30
Domain	I-BAR_dom	ARHGAP42 ARHGAP26	1.21e-03	13	75	2	IPR013606
Domain	PH_dom-like	ARHGAP42 ARHGAP26 KIF1B DOCK10 ARHGEF18 ARHGEF17 PLCE1	1.60e-03	426	75	7	IPR011993
Domain	Myosin_N	MYH13 MYH7B	1.62e-03	15	75	2	PF02736
Domain	Myosin_N	MYH13 MYH7B	1.62e-03	15	75	2	IPR004009
Domain	PH	ARHGAP42 ARHGAP26 KIF1B DOCK10 ARHGEF18	2.28e-03	229	75	5	PF00169
Domain	Myosin_tail_1	MYH13 MYH7B	2.34e-03	18	75	2	PF01576
Domain	Myosin_tail	MYH13 MYH7B	2.34e-03	18	75	2	IPR002928
Domain	Myosin-like_IQ_dom	MYH13 MYH7B	2.60e-03	19	75	2	IPR027401
Domain	-	MYH13 MYH7B	2.60e-03	19	75	2	4.10.270.10
Domain	Bromodomain_CS	BAZ1B BRWD1	4.86e-03	26	75	2	IPR018359
Domain	PH	ARHGAP42 ARHGAP26 KIF1B DOCK10 ARHGEF18	5.21e-03	278	75	5	SM00233
Domain	PH_DOMAIN	ARHGAP42 ARHGAP26 KIF1B DOCK10 ARHGEF18	5.29e-03	279	75	5	PS50003
Domain	Rho_GTPase_activation_prot	ARHGAP42 NF1 ARHGAP26	5.34e-03	88	75	3	IPR008936
Domain	PH_domain	ARHGAP42 ARHGAP26 KIF1B DOCK10 ARHGEF18	5.37e-03	280	75	5	IPR001849
Domain	FHA	KIF1B MKI67	5.62e-03	28	75	2	SM00240
Domain	FHA_DOMAIN	KIF1B MKI67	6.86e-03	31	75	2	PS50006
Domain	FHA	KIF1B MKI67	6.86e-03	31	75	2	PF00498
Pubmed	Tagging genes with cassette-exchange sites.	ZFAT ARHGAP26 GTSE1 MKI67 BAZ1B KDM7A REXO1L1P SOCS7	8.05e-07	335	77	8	15741177
Pubmed	Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling.	NF1 CORO2A RIMS3 ARHGEF18 PFKL HSPA2	9.53e-07	147	77	6	16959763
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	UBR1 PPIG NF1 MAPT RBBP8 KIF1B GTSE1 MKI67 BAZ1B ZMYM3 ZNF687	1.09e-06	774	77	11	15302935
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	URI1 NF1 MCPH1 MYH7B AFF3 CCDC18 BAZ1B ARHGEF18 ZC3HC1 KDM7A PFKL CCDC77 SOCS7	3.17e-06	1242	77	13	30973865
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RIMS3 KIF1B OBSL1 DOCK10 MAST1 ARHGEF17 ZMYM3 PLCE1	3.42e-06	407	77	8	12693553
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ZFAT MYH7B KIF1B PLCE1 BAHCC1	3.45e-06	103	77	5	10819331
Pubmed	Extragonadal teratocarcinoma in chimeric mice.	BRCA2 HSPA2	4.84e-06	2	77	2	10490215
Pubmed	DNA end resection requires constitutive sumoylation of CtIP by CBX4.	RBBP8 CBX4	4.84e-06	2	77	2	28740167
Pubmed	Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.	ESR2 MKI67	4.84e-06	2	77	2	18234277
Pubmed	KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors.	NF1 KIF1B	4.84e-06	2	77	2	28515046
Pubmed	Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry.	ESR2 MKI67	4.84e-06	2	77	2	25527409
Pubmed	Maternal Hypertension-Related Genotypes and Congenital Heart Defects.	ARHGAP42 PLCE1	4.84e-06	2	77	2	32710738
Pubmed	Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA.	NF1 KIF1B MKI67	5.72e-06	16	77	3	28637693
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	BRCA2 GTSE1 AFF3 CBX4 CCDC77 ZNF687	1.03e-05	222	77	6	37071664
Pubmed	Microcephalin regulates BRCA2 and Rad51-associated DNA double-strand break repair.	MCPH1 BRCA2	1.45e-05	3	77	2	19549900
Pubmed	Dendritic and axonal distribution of the microtubule-associated proteins MAP2 and tau in the cerebellum of the nervous mutant mouse.	MAPT HPS5	1.45e-05	3	77	2	3147150
Pubmed	Neurofibromatosis with male breast cancer--risk factor or co-incidence? Report of two rare cases.	NF1 BRCA2	1.45e-05	3	77	2	25267367
Pubmed	BRIT1/MCPH1 is essential for mitotic and meiotic recombination DNA repair and maintaining genomic stability in mice.	MCPH1 BRCA2	1.45e-05	3	77	2	20107607
Pubmed	Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.	MAPT ESR2	1.45e-05	3	77	2	18586097
Pubmed	Immunoexpression of estrogen receptor-β and progesterone receptor in prostate adenocarcinoma, does it inhibit neoplastic proliferation and invasion?	ESR2 MKI67	1.45e-05	3	77	2	32108623
Pubmed	Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancer.	ESR2 MKI67	1.45e-05	3	77	2	19593135
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NF1 MAPT PARP8 KIF1B GTSE1 CCDC18 CBX4 PPIP5K2 ARHGEF17 PPP1R12C	2.01e-05	861	77	10	36931259
Pubmed	Cereblon Regulates the Proteotoxicity of Tau by Tuning the Chaperone Activity of DNAJA1.	MAPT HSPA2	2.89e-05	4	77	2	33972400
Pubmed	Human Endometriosis Tissue Microarray Reveals Site-specific Expression of Estrogen Receptors, Progesterone Receptor, and Ki67.	ESR2 MKI67	2.89e-05	4	77	2	29629944
Pubmed	Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.	DENND2D ARHGEF17	2.89e-05	4	77	2	18677770
Pubmed	Microcephaly family protein MCPH1 stabilizes RAD51 filaments.	MCPH1 BRCA2	2.89e-05	4	77	2	32735676
Pubmed	A BAR domain-mediated autoinhibitory mechanism for RhoGAPs of the GRAF family.	ARHGAP42 ARHGAP26	2.89e-05	4	77	2	18954304
Pubmed	TDRD5 is required for retrotransposon silencing, chromatoid body assembly, and spermiogenesis in mice.	PIWIL4 ODF1 HSPA2	3.66e-05	29	77	3	21383078
Pubmed	Polycomb Group Protein CBX7 Represses Cardiomyocyte Proliferation Through Modulation of the TARDBP/RBM38 Axis.	MKI67 CBX4 PCGF5	4.06e-05	30	77	3	37158107
Pubmed	Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.	MCPH1 BRCA2 RBBP8	4.49e-05	31	77	3	19690177
Pubmed	Hormone receptors expression in phyllodes tumors of the breast.	ESR2 MKI67	4.82e-05	5	77	2	22590818
Pubmed	The Central Domain of MCPH1 Controls Development of the Cerebral Cortex and Gonads in Mice.	MCPH1 MKI67	4.82e-05	5	77	2	36078123
Pubmed	Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.	BRCA2 MKI67	7.22e-05	6	77	2	21404276
Pubmed	BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks.	BRCA2 RBBP8	7.22e-05	6	77	2	38554279
Pubmed	High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.	NF1 BRCA2	7.22e-05	6	77	2	28608929
Pubmed	PALB2 is an integral component of the BRCA complex required for homologous recombination repair.	BRCA2 RBBP8	7.22e-05	6	77	2	19369211
Pubmed	SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.	NF1 MKI67	7.22e-05	6	77	2	22118770
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	MKI67 BAZ1B ZMYM3 ZNF687	8.31e-05	103	77	4	32744500
Pubmed	MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway.	MCPH1 MKI67	1.01e-04	7	77	2	21947081
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	PPIG BRCA2 KIF1B GTSE1 HAUS5 PPIP5K2 CCDC77 HSPA2 BRWD1	1.12e-04	853	77	9	28718761
Pubmed	RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage.	BRCA2 RBBP8	1.34e-04	8	77	2	34408138
Pubmed	DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy.	PPIG RIMS3 KIF1B MKI67 ZC3HC1 BRWD1	1.60e-04	364	77	6	31391242
Pubmed	Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.	BRCA2 RBBP8	1.72e-04	9	77	2	24085845
Pubmed	Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance.	BRCA2 RBBP8	1.72e-04	9	77	2	28398198
Pubmed	Conserved overlapping gene arrangement, restricted expression, and biochemical activities of DNA polymerase ν (POLN).	BRCA2 RBBP8	1.72e-04	9	77	2	26269593
Pubmed	In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1.	NF1 MKI67	1.72e-04	9	77	2	22918885
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NUAK1 ARHGAP26 HAUS5 KDM7A PPIP5K2 HPS5 ZNF687	1.74e-04	529	77	7	14621295
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MAPT HAUS5 OBSL1 BAZ1B CBX4 INO80D ZMYM3 ZNF687 BAHCC1 BRWD1	1.74e-04	1116	77	10	31753913
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	MAPT MKI67	2.15e-04	10	77	2	22159418
Pubmed	Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.	BRCA2 ESR2	2.15e-04	10	77	2	18765668
Pubmed	MOV10L1 is necessary for protection of spermatocytes against retrotransposons by Piwi-interacting RNAs.	PIWIL4 HSPA2	2.15e-04	10	77	2	20547853
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	UBR1 URI1 ERCC3 ARHGEF18 PFKL HSPA2	2.32e-04	390	77	6	17643375
Pubmed	Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.	BRCA2 RBBP8	2.63e-04	11	77	2	19584272
Pubmed	Immune-related zinc finger gene ZFAT is an essential transcriptional regulator for hematopoietic differentiation in blood islands.	ZFAT MKI67	2.63e-04	11	77	2	20660741
Pubmed	Proteomics analysis of Ring1B/Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6 interacting corepressor.	CBX4 PCGF5 ZNF687	2.80e-04	57	77	3	17296600
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	ERCC3 NF1 HAUS5 MKI67 DOCK10 ARHGEF18	3.03e-04	410	77	6	26949251
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NF1 CORO2A MAPT ARHGAP26 KIF1B MAST1 ZC3HC1 PFKL ARHGEF17 HSPA2 PPP1R12C	3.04e-04	1431	77	11	37142655
Pubmed	Genetically engineered mouse models of brain cancer and the promise of preclinical testing.	NF1 BRCA2	3.15e-04	12	77	2	19076778
Pubmed	CAMSAP1 breaks the homeostatic microtubule network to instruct neuronal polarity.	MAPT MKI67	3.15e-04	12	77	2	32839317
Pubmed	Molecular Characterization of Nodose Ganglia Development Reveals a Novel Population of Phox2b+ Glial Progenitors in Mice.	MAPT MKI67	3.15e-04	12	77	2	38830761
Pubmed	Interplay between Polo kinase, LKB1-activated NUAK1 kinase, PP1βMYPT1 phosphatase complex and the SCFβTrCP E3 ubiquitin ligase.	NUAK1 PPP1R12C	3.15e-04	12	77	2	24785407
Pubmed	Mouse models in tumor suppression.	NF1 BRCA2	3.15e-04	12	77	2	9917000
Pubmed	A cochlear progenitor pool influences patterning of the mammalian sensory epithelium via MYBL2.	MKI67 PORCN	3.15e-04	12	77	2	39254648
Pubmed	Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.	BRCA2 RBBP8	3.15e-04	12	77	2	16391231
Pubmed	The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium.	KIF1B MKI67	3.15e-04	12	77	2	15834408
Pubmed	SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.	BRCA2 MKI67	3.15e-04	12	77	2	34267330
Pubmed	Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.	NF1 MKI67	3.15e-04	12	77	2	22789544
Pubmed	Pax6 interactions with chromatin and identification of its novel direct target genes in lens and forebrain.	FAT4 KIF1B	3.15e-04	12	77	2	23342162
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BRCA2 RBBP8 KIF1B OBSL1 BAZ1B CBX4 ZMYM3	3.30e-04	588	77	7	38580884
Pubmed	A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein.	URI1 HSPA2 PLCE1	3.42e-04	61	77	3	19875381
Pubmed	hnRNPU is required for spermatogonial stem cell pool establishment in mice.	MKI67 PIWIL4	3.71e-04	13	77	2	38625792
Pubmed	SWI/SNF chromatin remodeling complex is required for initiation of sex-dependent differentiation in mouse germline.	MKI67 PIWIL4	3.71e-04	13	77	2	34912016
Pubmed	Involvement of SF-1 in neurogenesis and neuronal migration in the developing neocortex.	ESR2 MKI67	3.71e-04	13	77	2	26067405
Pubmed	Family with sequence similarity 60A (FAM60A) protein is a cell cycle-fluctuating regulator of the SIN3-HDAC1 histone deacetylase complex.	MKI67 PFKL BAHCC1	3.94e-04	64	77	3	22865885
Pubmed	The E3 ubiquitin ligase APC/CCdh1 degrades MCPH1 after MCPH1-βTrCP2-Cdc25A-mediated mitotic entry to ensure neurogenesis.	MCPH1 OBSL1 CCDC77	4.13e-04	65	77	3	29150431
Pubmed	Tbx5 is required for avian and Mammalian epicardial formation and coronary vasculogenesis.	MKI67 FREM3	4.33e-04	14	77	2	25245104
Pubmed	The RNA helicase MOV10L1 binds piRNA precursors to initiate piRNA processing.	PIWIL4 ODF1	4.99e-04	15	77	2	25762440
Pubmed	Developmental Requirement of Homeoprotein Otx2 for Specific Habenulo-Interpeduncular Subcircuits.	MAPT MKI67	4.99e-04	15	77	2	30593496
Pubmed	Primary Autosomal Recessive Microcephalies and Seckel Syndrome Spectrum Disorders – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	MCPH1 RBBP8	5.69e-04	16	77	2	20301772
Pubmed	Neuronal-specific deficiency of the splicing factor Tra2b causes apoptosis in neurogenic areas of the developing mouse brain.	MAPT MKI67	5.69e-04	16	77	2	24586484
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ERCC3 HAUS5 CCDC18 ZC3HC1 CBX4 CCDC77 ZNF687	5.72e-04	645	77	7	25281560
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	UBR1 OBSL1 DOCK10 PFKL PPIP5K2 HPS5 PLCE1	5.98e-04	650	77	7	38777146
Pubmed	BRCA1 and BRCA2 tumor suppressors in neural crest cells are essential for craniofacial bone development.	BRCA2 MKI67	6.44e-04	17	77	2	29718910
Pubmed	Cbx4 regulates the proliferation of thymic epithelial cells and thymus function.	MKI67 CBX4	6.44e-04	17	77	2	23362346
Pubmed	Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease.	FAT4 PPP1R12C	6.44e-04	17	77	2	22153077
Pubmed	The expression pattern of nuclear receptors during cerebellar development.	ESR2 MKI67	6.44e-04	17	77	2	17205580
Pubmed	NANOS2 promotes male germ cell development independent of meiosis suppression.	MKI67 PIWIL4	7.23e-04	18	77	2	24183939
Pubmed	Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.	BRCA2 MKI67	7.23e-04	18	77	2	19584075
Pubmed	Fat1 interacts with Fat4 to regulate neural tube closure, neural progenitor proliferation and apical constriction during mouse brain development.	FAT4 MKI67	7.23e-04	18	77	2	26209645
Pubmed	Wilms Tumor Predisposition	NF1 BRCA2	7.23e-04	18	77	2	20301471
Pubmed	Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.	FAT4 MKI67	7.23e-04	18	77	2	33108146
Pubmed	Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.	RBBP8 KIF1B	8.07e-04	19	77	2	14578343
Pubmed	Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.	NF1 MKI67	8.07e-04	19	77	2	34428430
Pubmed	Functional Cooperation of α-Synuclein and Tau Is Essential for Proper Corticogenesis.	MAPT MKI67	8.07e-04	19	77	2	35906071
Pubmed	Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.	NF1 MKI67	8.07e-04	19	77	2	25535838
Pubmed	Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates.	MYH13 MKI67	8.96e-04	20	77	2	19531352
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	ERCC3 NF1 MYH13 NUAK1 AFF3 OBSL1 PCGF5 ZNF687	9.12e-04	910	77	8	36736316
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	MKI67 BAZ1B BRWD1	9.36e-04	86	77	3	37253089
Pubmed	Molecular Profiling Reveals Involvement of ESCO2 in Intermediate Progenitor Cell Maintenance in the Developing Mouse Cortex.	GTSE1 MKI67 ZNF687	9.68e-04	87	77	3	33798452
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	RBBP8 MKI67 BAZ1B CBX4 ZNF687	9.76e-04	341	77	5	32971831
Interaction	PMVK interactions	NF1 MCPH1 MAPT ESR2 MKI67 ZC3HC1	1.92e-06	101	74	6	int:PMVK
Interaction	YWHAZ interactions	NF1 CORO2A MAPT ESR2 PARP8 RIMS3 KIF1B CCDC18 OBSL1 MAST1 ARHGEF18 CBX4 PFKL PPIP5K2 HSPA2 PCGF5 PPP1R12C	4.34e-06	1319	74	17	int:YWHAZ
Interaction	FOXP4 interactions	ESR2 MKI67 PFKL ZMYM3 ZNF687	3.03e-05	98	74	5	int:FOXP4
Interaction	PNMA2 interactions	PPIG KIF1B GTSE1 MAST1 CBX4 ZNF865 ZNF687	3.78e-05	251	74	7	int:PNMA2
Interaction	APBA1 interactions	UBR1 MAPT KIF1B GTSE1 MKI67	3.85e-05	103	74	5	int:APBA1
Interaction	YWHAG interactions	PPIG NF1 NUAK1 MAPT ESR2 PARP8 RIMS3 KIF1B GTSE1 CCDC18 CBX4 PPIP5K2 ARHGEF17 ZMYM3 PPP1R12C	3.98e-05	1248	74	15	int:YWHAG
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	DNLZ ZC3HC1	1.07e-03	15	59	2	26
GeneFamily	Myosin heavy chains	MYH13 MYH7B	1.07e-03	15	59	2	1098
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE	ARHGAP42 MAPT ARHGAP26 ARHGEF17 TNFRSF21 HSPA2 PLCE1	1.60e-06	195	76	7	M45684
ToppCell	myeloid-pro-pDC\|World / Lineage and Cell class	BRCA2 GTSE1 MKI67 GAPT TNFRSF21 BAHCC1	1.20e-06	197	77	6	8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5
ToppCell	mild-pDC\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZFAT BRCA2 RIMS3 AFF3 GAPT TNFRSF21	1.20e-06	197	77	6	15230a54fa5903dd728de1a0ad633bd2d2c7a04d
ToppCell	severe-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZFAT RIMS3 AFF3 GAPT CBX4 TNFRSF21	1.23e-06	198	77	6	3c4820a8391088682fb3e47b914f872533bae227
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	7.59e-06	156	77	5	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	7.83e-06	157	77	5	bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SH3TC2 BRCA2 GTSE1 CCDC18 MKI67	9.96e-06	165	77	5	eec2d327c94832d1390314c93ef6a2be4648478b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SH3TC2 BRCA2 GTSE1 CCDC18 MKI67	1.06e-05	167	77	5	50c29ea660bf07b890e4ac1a1985d0761d863dee
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SH3TC2 BRCA2 GTSE1 CCDC18 MKI67	1.12e-05	169	77	5	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 GTSE1 AFF3 CCDC18 MKI67	1.12e-05	169	77	5	54b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCell	10x5'-blood-Myeloid_Dendritic-pDC\|blood / Manually curated celltypes from each tissue	ZFAT AFF3 OBSL1 TNFRSF21 BAHCC1	1.15e-05	170	77	5	59cb1262ff319349d42b11afbec2a9035b7b79f2
ToppCell	COVID_vent-Lymphocytic-Dendritic-pDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ZFAT RIMS3 AFF3 GAPT TNFRSF21	1.18e-05	171	77	5	779c951d274ecbd1d546ac425d6c8e718623be5a
ToppCell	COVID_vent-Lymphocytic-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ZFAT RIMS3 AFF3 GAPT TNFRSF21	1.18e-05	171	77	5	debbb071d260639b16269c94d172766908325c58
ToppCell	COVID-19_Mild-PLT_2\|COVID-19_Mild / Disease Group and Platelet Clusters	ARHGAP42 MCPH1 GTSE1 HAUS5 ZC3HC1	1.25e-05	173	77	5	d11705e56b6b21eec963ea224717f27680c781ed
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SH3TC2 BRCA2 GTSE1 CCDC18 MKI67	1.29e-05	174	77	5	84da9faff088d05233183b425385beb054c92d1b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SH3TC2 BRCA2 GTSE1 CCDC18 MKI67	1.29e-05	174	77	5	dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP42 BRCA2 RBBP8 GTSE1 MKI67	1.32e-05	175	77	5	0b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCell	NS-moderate-d_0-4-Myeloid-pDC\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZFAT BRCA2 ESR2 GAPT ARHGEF17	1.40e-05	177	77	5	de1ffe3df76100d46ca158bdd2fea2ebbd4656b4
ToppCell	Severe-Lymphoid-pDC\|Severe / Condition, Lineage, Cell class and cell subclass	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.56e-05	181	77	5	2caecb7c5dcdad46fd02b4ffb73cb613ce835187
ToppCell	Severe-Lymphoid-pDC-\|Severe / Condition, Lineage, Cell class and cell subclass	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.56e-05	181	77	5	277ce4c49121da0990a5933b19d2c6af9bbe253e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 GTSE1 CCDC18 MKI67 CCDC77	1.60e-05	182	77	5	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBBP8 GTSE1 HAUS5 MKI67 GAPT	1.60e-05	182	77	5	11494a66d986297b837332ee9d382b71b9f22591
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	1.64e-05	183	77	5	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	1.69e-05	184	77	5	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCPH1 BRCA2 CORO2A MKI67 PFKL	1.69e-05	184	77	5	185b49630da61cbf45c0926d1b992943296d2a54
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MAPT RIMS3 ARHGEF17 PLCE1	1.69e-05	184	77	5	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GTSE1 CCDC18 MKI67 GAPT GRAMD1C	1.73e-05	185	77	5	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.73e-05	185	77	5	f4588468e8654363f48adbe427dff10f16f1c7fe
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.73e-05	185	77	5	3cb816fc9541c04b4436e21d984216cfbbacff98
ToppCell	ICU-NoSEP-Myeloid-pDC\|ICU-NoSEP / Disease, Lineage and Cell Type	ZFAT RIMS3 AFF3 GAPT TNFRSF21	1.73e-05	185	77	5	7564a47df4a4e3af30d40aa0f48bd9d9c82358ae
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.73e-05	185	77	5	c2e70405969616c28fb6379ee318e17bbcef7b49
ToppCell	Mild-Lymphoid-pDC\|Mild / Condition, Lineage, Cell class and cell subclass	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.78e-05	186	77	5	7fa82972c726025d6402e5eb7bf0db3b699eba4c
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.78e-05	186	77	5	b031f4e6867b6200b85f43276a34749bf5f4603f
ToppCell	healthy_donor-Lymphocytic-Dendritic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ZFAT RIMS3 OBSL1 GAPT TNFRSF21	1.78e-05	186	77	5	916f2aeea4989ba7a29e071e348a51010f010223
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.78e-05	186	77	5	d2fbf53aac905c9896272ec5c2db28ee1a60f4be
ToppCell	healthy_donor-Lymphocytic-Dendritic-pDC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ZFAT RIMS3 OBSL1 GAPT TNFRSF21	1.78e-05	186	77	5	45f66619e45d590c7365a51782d4ac46b7d31fde
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ARHGAP42 UBR1 PPIG HMCN1 SRFBP1	1.78e-05	186	77	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Mild-Lymphoid-pDC-\|Mild / Condition, Lineage, Cell class and cell subclass	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.78e-05	186	77	5	1d05e73ae2ec0cc27f79e4fa40d6b21790059f80
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.78e-05	186	77	5	79aedd5aed72509a4925e9f6cb43bc0c798c86f5
ToppCell	Mild_COVID-19-Myeloid-pDC\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ZFAT ESR2 AFF3 GAPT TNFRSF21	1.82e-05	187	77	5	99c3c4a7b9179dce7982dc6516d561c952abc80e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 GTSE1 CCDC18 MKI67 CCDC77	1.82e-05	187	77	5	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 GTSE1 CCDC18 MKI67 DOCK10	1.82e-05	187	77	5	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	control-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZFAT RIMS3 OBSL1 GAPT TNFRSF21	1.82e-05	187	77	5	c78aee98b32719aa45811b620fc97be1ecf5fd53
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	1.92e-05	189	77	5	26cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	1.97e-05	190	77	5	2ab604d35456beba71c25511e0f819000e6642d2
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARHGAP42 MAPT MKI67 ARHGEF17 TNFRSF21	2.02e-05	191	77	5	ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARHGAP42 MAPT DOCK10 ARHGEF17 TNFRSF21	2.02e-05	191	77	5	2ad717b59215ad8d933e9637d363b65d7298e5d4
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MAPT ARHGAP26 ARHGEF17 HSPA2 PLCE1	2.07e-05	192	77	5	55f95454399fd533df75db06584eaa48d6ee3830
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MAPT ARHGAP26 ARHGEF17 HSPA2 PLCE1	2.07e-05	192	77	5	5000440dc1ed17e7474d340921bdff945646f27e
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	BRCA2 GTSE1 CCDC18 MKI67 CCDC77	2.12e-05	193	77	5	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	control-pDC\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZFAT RIMS3 OBSL1 GAPT TNFRSF21	2.12e-05	193	77	5	30a6559c9a9e8941861cb259b4836acccc427e68
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA2 GTSE1 CCDC18 MKI67 CBX4	2.12e-05	193	77	5	e45ce9cf8421512b57f157c24b64793b47b4ba4b
ToppCell	mild-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZFAT BRCA2 AFF3 GAPT TNFRSF21	2.34e-05	197	77	5	0cb00daa6943f7a7fb34a8fdf51188646af65686
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGAP42 MAPT ARHGEF17 HSPA2 PLCE1	2.34e-05	197	77	5	fd65a9b41df618ff2a09d76dcf9f1ca3f3bdf52a
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ARHGAP42 MAPT ARHGEF17 HSPA2 PLCE1	2.34e-05	197	77	5	44cd1ece3633a31e8c9b667cd3cbc2749c06f478
ToppCell	Biopsy_IPF-Immune-pDCs\|Biopsy_IPF / Sample group, Lineage and Cell type	ZFAT RIMS3 AFF3 GAPT TNFRSF21	2.40e-05	198	77	5	aa8943e6796f619406056cf763b751fe9a9a3e0c
ToppCell	severe-pDC\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZFAT RIMS3 AFF3 GAPT TNFRSF21	2.40e-05	198	77	5	22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ARHGAP42 MAPT ARHGEF17 HSPA2 PLCE1	2.40e-05	198	77	5	76d46950c11cb4708866db0da54ce00d5c0adab8
ToppCell	Sepsis-ICU-NoSEP-Myeloid-pDC\|ICU-NoSEP / Disease, condition lineage and cell class	ZFAT RIMS3 AFF3 GAPT TNFRSF21	2.46e-05	199	77	5	a199e67438eeed903d0996605591ec54400fdd66
ToppCell	distal-mesenchymal-Pericyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ARHGAP42 ARHGEF17 TNFRSF21 HSPA2 PLCE1	2.46e-05	199	77	5	000d9b5f5a48e56f0733390adb3d7270c49a4a1a
ToppCell	distal-3-mesenchymal-Pericyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ARHGAP42 ARHGEF17 TNFRSF21 HSPA2 PLCE1	2.52e-05	200	77	5	911db29f254bb697610e720ba78816e2c7f57933
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	2.52e-05	200	77	5	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	2.52e-05	200	77	5	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	2.52e-05	200	77	5	4e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	2.52e-05	200	77	5	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	BRCA2 GTSE1 CCDC18 MKI67 HSPA2	2.52e-05	200	77	5	203b9a5de4430713da01b3331e69381db449a3a0
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	BRCA2 GTSE1 CCDC18 MKI67 HSPA2	2.52e-05	200	77	5	a854e19703dc920e48304541e2b06ed013292f3e
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ARHGAP42 MAPT ARHGEF17 TNFRSF21 PLCE1	2.52e-05	200	77	5	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	severe-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BRCA2 CORO2A KIF1B MKI67 PIWIL4	2.52e-05	200	77	5	5ee43386da8261d2e7602a152e6ba4338d844e08
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_only / Treatment groups by lineage, cell group, cell type	ARHGAP42 MAPT RIMS3 ARHGEF17 PLCE1	2.52e-05	200	77	5	69edc375d85689300d1dbc1217fedc40063ecdcb
ToppCell	368C-Epithelial_cells-Epithelial-B_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CORO2A CCDC18 DUSP19 CCDC77	3.58e-05	107	77	4	410b37beffaf637a2a64c9d0ce7baf81f4bc667c
ToppCell	368C-Epithelial_cells-Epithelial-B_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CORO2A CCDC18 DUSP19 CCDC77	3.58e-05	107	77	4	5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7
ToppCell	LPS_only-Unknown-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAPT RIMS3 TNFRSF21 PLCE1	4.75e-05	115	77	4	ad5298c2ad8bf94fa13c2e50b0799e929473ef59
ToppCell	LPS_only-Unknown\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAPT RIMS3 TNFRSF21 PLCE1	4.75e-05	115	77	4	7a733f6987b40ec497a03734b79ed5355ad3a2fc
ToppCell	LPS_only-Unknown-Endothelial-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAPT RIMS3 TNFRSF21 PLCE1	4.75e-05	115	77	4	c67145d3cd9243994a141749b426ff2a6dcc8d93
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse\|TCGA-Stomach / Sample_Type by Project: Shred V9	AFF3 DOCK10 GAPT ARHGEF18	7.42e-05	129	77	4	7d537680b0dfb764f7914d0475c66b678b5cb8d2
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CORO2A MKI67 KDM7A PCGF5	1.20e-04	146	77	4	45d7cb73776e60d22f335a651845e21e16948fcc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 GTSE1 MKI67 MAST1	1.55e-04	156	77	4	b3f10cd044f24807576e7d56e51df7064dbf6c50
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SH3TC2 CCDC18 DOCK10 CCDC77	1.55e-04	156	77	4	fbe23876f0899853cea3c5c4f3044a9cea064d5b
ToppCell	356C-Myeloid-Dendritic-pDC\|356C / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP42 ZFAT GAPT ZNF891	1.55e-04	156	77	4	d9d87368e43b24952e70f31f38425e15b716ff5b
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3TC2 BRCA2 KCNB2 GRAMD1C	1.70e-04	160	77	4	f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41
ToppCell	COVID_non-vent-Lymphocytic-Dendritic-pDC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ZFAT RIMS3 GAPT TNFRSF21	1.70e-04	160	77	4	61f4cb4eb4313d8318aadbb99595a6cb7fd919f7
ToppCell	COVID_non-vent-Lymphocytic-Dendritic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ZFAT RIMS3 GAPT TNFRSF21	1.70e-04	160	77	4	34b4f710cfcb6ec370b8b074f3cbfe272f392cec
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|367C / Donor, Lineage, Cell class and subclass (all cells)	GTSE1 CCDC18 MKI67 CBX4	1.87e-04	164	77	4	0662cd9d21608efacc336e0a582859f3b9a4951d
ToppCell	367C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZFAT AFF3 TNFRSF21 ZNF891	1.87e-04	164	77	4	95b800c78871354c859abaa832d778786ef7bcc0
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZFAT RIMS3 AFF3 GAPT	1.92e-04	165	77	4	e2a70dd5870fe8708bf630ed3e6eb3f295df0cdf
ToppCell	droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERCC3 LZTFL1 BAZ1B BAHCC1	1.92e-04	165	77	4	1d0f60bf47a40ac916f0fcb5532a968742a0edbb
ToppCell	Dividing_Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	BRCA2 GTSE1 MKI67 MAST1	1.96e-04	166	77	4	c503036f3c19ef186e1e62c9643c49dea3827f51
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PARP8 HAUS5 MAST1 ZNF766	1.96e-04	166	77	4	e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889
ToppCell	10x5'-Liver-Hematopoietic_progenitors\|Liver / Manually curated celltypes from each tissue	BRCA2 GTSE1 MKI67 BAHCC1	1.96e-04	166	77	4	ae967570248cf86ca3ddf55e33bcbb3e4e3684bc
ToppCell	10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Liver / Manually curated celltypes from each tissue	BRCA2 GTSE1 MKI67 BAHCC1	1.96e-04	166	77	4	a176e87aa6eec81d1fb79a028f759182d11b567d
ToppCell	10x5'-Liver-Myeloid_Dendritic-pDC\|Liver / Manually curated celltypes from each tissue	ZFAT AFF3 GAPT TNFRSF21	1.96e-04	166	77	4	24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44
ToppCell	367C-Myeloid-Dendritic-pDC\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZFAT AFF3 TNFRSF21 ZNF891	2.01e-04	167	77	4	650de8cd5df070639b8aa292aacead739cfdb02c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RBBP8 GTSE1 MKI67 HSPA2	2.01e-04	167	77	4	9280558baddea51aae47f3383d895a9b0c6749a4
ToppCell	facs-MAT-Fat-18m-Myeloid-macrophage\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CORO2A DOCK10 GAPT TNFRSF21	2.01e-04	167	77	4	c2952d8ba763374c5678b92825c8956fc3e3ecd2
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP42 ERCC3 MAPT TNFRSF21	2.01e-04	167	77	4	b0eb7a40491dd2432f5282f578ce569df86d21a7
ToppCell	NS-moderate-d_07-13-Myeloid-pDC\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZFAT RIMS3 AFF3 GAPT	2.05e-04	168	77	4	d03e91f0e0518b33555c0ec98124fc5ed0f11be5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SH3TC2 BRCA2 GTSE1 MKI67	2.05e-04	168	77	4	d35944fd9fea9934ce1e76b2b35d48e2300cca61
ToppCell	(3)_DC_plasmacytoid\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ZFAT GAPT TNFRSF21 ZNF891	2.05e-04	168	77	4	8a913db9b2a1a4ff96fb139734a3834e6aa263f1
ToppCell	(3)_MNP-(3)_DC_plasmacytoid\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	ZFAT AFF3 TNFRSF21 ZNF891	2.05e-04	168	77	4	13c160ea1a19b47d2e7e2dae818c8dcde4e3e377
ToppCell	390C-Myeloid-Dendritic-pDC\|390C / Donor, Lineage, Cell class and subclass (all cells)	ZFAT AFF3 GAPT TNFRSF21	2.05e-04	168	77	4	5a2e7a52b7330dce30823695a7b9b26bc47a69ce
Disease	JUVENILE MYELOMONOCYTIC LEUKEMIA	NF1 ARHGAP26	3.71e-05	4	74	2	607785
Disease	Juvenile myelomonocytic leukemia	NF1 ARHGAP26	3.71e-05	4	74	2	cv:C0349639
Disease	X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology)	ARHGAP42 ARHGAP26	3.71e-05	4	74	2	DOID:0080311 (implicated_via_orthology)
Disease	chronic obstructive pulmonary disease	MTHFSD HMCN1 KIF1B AFF3 DOCK10 DENND2D SRFBP1 FREM3 ARHGEF17	5.53e-05	688	74	9	EFO_0000341
Disease	juvenile myelomonocytic leukemia (is_implicated_in)	NF1 ARHGAP26	1.29e-04	7	74	2	DOID:0050458 (is_implicated_in)
Disease	Carcinoma, Granular Cell	FAT4 ESR2 MKI67 PLCE1	2.11e-04	116	74	4	C0205644
Disease	Adenocarcinoma, Tubular	FAT4 ESR2 MKI67 PLCE1	2.11e-04	116	74	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	FAT4 ESR2 MKI67 PLCE1	2.11e-04	116	74	4	C0205642
Disease	Carcinoma, Cribriform	FAT4 ESR2 MKI67 PLCE1	2.11e-04	116	74	4	C0205643
Disease	Adenocarcinoma, Basal Cell	FAT4 ESR2 MKI67 PLCE1	2.11e-04	116	74	4	C0205641
Disease	Adenocarcinoma	FAT4 ESR2 MKI67 PLCE1	2.11e-04	116	74	4	C0001418
Disease	FEV/FEC ratio	ARHGAP42 MTHFSD HMCN1 ARHGAP26 KIF1B AFF3 ARHGEF18 KDM7A DENND2D SRFBP1 ARHGEF17	2.34e-04	1228	74	11	EFO_0004713
Disease	vital capacity	SH3TC2 ZFAT HMCN1 DNLZ MAPT RBBP8 MYH7B ARHGAP26 AFF3 PCGF5 PLCE1	2.47e-04	1236	74	11	EFO_0004312
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH13 MYH7B	2.76e-04	10	74	2	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH13 MYH7B	2.76e-04	10	74	2	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH13 MYH7B	2.76e-04	10	74	2	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH13 MYH7B	2.76e-04	10	74	2	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH13 MYH7B	2.76e-04	10	74	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH13 MYH7B	2.76e-04	10	74	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH13 MYH7B	2.76e-04	10	74	2	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH13 MYH7B	2.76e-04	10	74	2	DOID:0111596 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH13 MYH7B	4.03e-04	12	74	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH13 MYH7B	4.03e-04	12	74	2	DOID:2106 (implicated_via_orthology)
Disease	Oligospermia	PIWIL4 BRWD1	4.03e-04	12	74	2	C0028960
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH13 MYH7B	4.75e-04	13	74	2	DOID:397 (implicated_via_orthology)
Disease	Benign tumor of pancreas	BRCA2 RBBP8	4.75e-04	13	74	2	C0347284
Disease	breast cancer (is_implicated_in)	MCPH1 BRCA2 ESR2 MKI67	5.60e-04	150	74	4	DOID:1612 (is_implicated_in)
Disease	glycerate measurement	HMCN1 LZTFL1	6.38e-04	15	74	2	EFO_0021029
Disease	RASopathy	NF1 ARHGAP26	6.38e-04	15	74	2	cv:C5555857
Disease	distal arthrogryposis (implicated_via_orthology)	MYH13 MYH7B	6.38e-04	15	74	2	DOID:0050646 (implicated_via_orthology)
Disease	Pheochromocytoma, Extra-Adrenal	NF1 KIF1B	7.28e-04	16	74	2	C1257877
Disease	protein C measurement	MYH7B BAZ1B	8.24e-04	17	74	2	EFO_0004633
Disease	QRS duration	ARHGAP42 FAT4 HMCN1 MYH7B OBSL1	9.26e-04	298	74	5	EFO_0005055
Disease	hematocrit	MAPT ARHGAP26 ESR2 KIF1B AFF3 ZC3HC1 PFKL PCGF5 BAHCC1	9.43e-04	1011	74	9	EFO_0004348
Disease	Pancreatic carcinoma	BRCA2 RBBP8	1.03e-03	19	74	2	C0235974
Disease	Juvenile Myelomonocytic Leukemia	NF1 ARHGAP26	1.03e-03	19	74	2	C0349639
Disease	Pheochromocytoma	NF1 KIF1B	1.03e-03	19	74	2	C0031511
Disease	eosinophil count	SH3TC2 ZFAT MAPT RBBP8 ARHGAP26 PARP8 LZTFL1 CCDC18 ARHGEF18 ZC3HC1 BAHCC1	1.16e-03	1488	74	11	EFO_0004842
Disease	in situ carcinoma (is_marker_for)	ESR2 MKI67	1.26e-03	21	74	2	DOID:8719 (is_marker_for)
Disease	testosterone measurement	UBR1 NF1 HMCN1 MAPT ARHGAP26 ESR2 BAZ1B ZC3HC1 DENND2D BRWD1	1.27e-03	1275	74	10	EFO_0004908
Disease	Primary microcephaly	MCPH1 RBBP8	1.39e-03	22	74	2	C0431350
Disease	Hereditary Paraganglioma-Pheochromocytoma Syndrome	NF1 KIF1B	1.52e-03	23	74	2	C1708353
Disease	HbA1c measurement	ZFAT DNLZ BAZ1B MAST1 DENND2D PFKL FREM3	1.52e-03	675	74	7	EFO_0004541
Disease	Coronary heart disease	ESR2 ZC3HC1	1.65e-03	24	74	2	C0010068
Disease	Neoplasm of the genitourinary tract	BRCA2 BCL10	1.65e-03	24	74	2	cv:C0042065
Disease	Cerebral Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0750935
Disease	Intracranial Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0750936
Disease	Pilocytic Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0334583
Disease	Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0004114
Disease	Juvenile Pilocytic Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0280783
Disease	Diffuse Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0280785
Disease	Grade I Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C1704230
Disease	response to interferon	ARHGAP26 PLCE1	1.79e-03	25	74	2	EFO_0007859
Disease	breast cancer (implicated_via_orthology)	BRCA2 ESR2	1.79e-03	25	74	2	DOID:1612 (implicated_via_orthology)
Disease	Subependymal Giant Cell Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0205768
Disease	Mixed oligoastrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0547065
Disease	Childhood Cerebral Astrocytoma	NF1 ESR2	1.79e-03	25	74	2	C0338070
Disease	myocardial infarction	ARHGAP42 ANKRD31 ARHGAP26 ZC3HC1 SRFBP1	1.88e-03	350	74	5	EFO_0000612
Disease	Gemistocytic astrocytoma	NF1 ESR2	1.94e-03	26	74	2	C0334581
Disease	Protoplasmic astrocytoma	NF1 ESR2	1.94e-03	26	74	2	C0334580
Disease	Fibrillary Astrocytoma	NF1 ESR2	1.94e-03	26	74	2	C0334582
Disease	Calcium channel blocker use measurement	ARHGAP42 ARHGEF18 ZC3HC1 PLCE1	2.05e-03	213	74	4	EFO_0009930
Disease	Anaplastic astrocytoma	NF1 ESR2	2.09e-03	27	74	2	C0334579
Disease	Developmental Academic Disorder	NF1 MAPT	2.41e-03	29	74	2	C1330966
Disease	Learning Disorders	NF1 MAPT	2.41e-03	29	74	2	C0023186
Disease	Learning Disturbance	NF1 MAPT	2.41e-03	29	74	2	C0751263
Disease	Adult Learning Disorders	NF1 MAPT	2.41e-03	29	74	2	C0751262
Disease	Learning Disabilities	NF1 MAPT	2.41e-03	29	74	2	C0751265
Disease	respiratory failure, COVID-19	MAPT LZTFL1	2.41e-03	29	74	2	EFO_0009686, MONDO_0100096
Disease	atrial fibrillation	ZFAT MAPT ARHGAP26 ESR2 KIF1B	2.42e-03	371	74	5	EFO_0000275

Protein segments in the cluster

Peptide	Gene	Start	Entry
SHRKELRSSVTCEKR	AFF3	636	P51826
LRSSVTCEKRRTRGL	AFF3	641	P51826
ALLVSSSCRRTKKVS	BAHCC1	2046	Q9P281
TSVKRRLSCLRSRVT	ARHGEF18	256	Q6ZSZ5
IRSSKQKCRLRVSTD	GRAMD1C	441	Q8IYS0
NTCISRLEKTRSKSE	RBBP8	366	Q99708
KRSALSCVISKTARL	BAZ1B	491	Q9UIG0
SCLRRLAVSSVLKSR	FAT4	3816	Q6V0I7
CRKRTVVSKRGVAVS	CCDC77	11	Q9BR77
VCTTLKRKSGSLRRS	ARHGEF17	1316	Q96PE2
ACVLRRSSRLEKLKV	ANKRD31	381	Q8N7Z5
NSRTTTLLRVKCVKH	OBSL1	501	O75147
KLLRRTCSSTVKTDD	PARP8	316	Q8N3A8
RCSTRVTVGTIKKFL	PCGF5	166	Q86SE9
LSRSQKCIRKEGSSE	KDM7A	821	Q6ZMT4
ARSKRGLRLKTVDSC	LZTFL1	21	Q9NQ48
QLSCRSLSKKERTSI	MCPH1	441	Q8NEM0
RETLKRKVSGNRCAS	ESR2	121	Q92731
TIRSKLSRRCPSQSK	KIF1B	1801	O60333
DSSRLKCTSIAVSRK	HPS5	31	Q9UPZ3
LRTACERAKRTLSSS	HSPA2	266	P54652
TLTRAKASAEKLCRT	MYH7B	1286	A7E2Y1
ILCRIRGSSSEAKNK	OR4N2	221	Q8NGD1
RSKEGRRKALSTCAS	OR4Q2	226	P0C623
SCDRIKQSASGTKRR	PFKL	551	P17858
FLQRRSSRRKVCTKT	GAPT	46	Q8N292
SKSVQRVTRSVKRCA	MKI67	3216	P46013
RLLIKGNSASKTRLC	HAUS5	401	O94927
AKLRRTTNRILASSC	ODF1	106	Q14990
KTRSIRRRDSCLNSK	GTSE1	426	Q9NYZ3
TKSCRTSNRKSLILT	MAST1	26	Q9Y2H9
TSLSRTRRTIRKTCP	HMCN1	5406	Q96RW7
RAQSRSRECDITKGK	PPIG	541	Q13427
KRLARILSACVLSKR	PORCN	366	Q9H237
DIIRSKTCSRRVKIN	KCNB2	26	Q92953
SKRGVDQTCTRVISK	DOCK10	2156	Q96BY6
RLKRRCTTSLIKEQE	BRCA2	3381	P51587
KVCGTRSSKRISKLA	DNLZ	76	Q5SXM8
KCTKLRRSISASDLT	CCDC18	1346	Q5T9S5
SCRTSSRKRAGKLLD	BCL10	56	O95999
NGSLLATTCKDRKIR	CORO2A	191	Q92828
ACKTTATTSSKRIVR	REXO1L1P	256	Q8IX06
REPCKKRLTARSIST	CBX4	421	O00257
RRKSLLTRKVICKSD	GOLPH3	111	Q9H4A6
NGLSRKISRKRVCSS	BRWD1	1891	Q9NSI6
RITRRCAATAANKIK	BRWD1	1926	Q9NSI6
RAACSRTSISRTKLR	INO80D	426	Q53TQ3
KSLVGVTAACTVRKR	ERCC3	346	P19447
ERSFCKALTSKTNRR	DENND2D	406	Q9H6A0
ASLKSGATATRRCRL	FREM3	196	P0C091
RKSILKSRSRENSVC	URI1	406	O94763
RRSSVCRLSSREKIS	PPP1R12C	341	Q9BZL4
VVCSIRKSSRTLKKG	TNFRSF21	366	O75509
KSKKERSTLLVRRFC	PLCE1	316	Q9P212
SRRTRAICLSTGSRK	ARHGAP42	591	A6NI28
TKKLRSNIRRSTETG	RIMS3	76	Q9UJD0
SVILKSCTRRKTDSI	ARHGAP26	316	Q9UNA1
NTSSRLSVIVVRKKC	PIWIL4	721	Q7Z3Z4
TARSLRRSLTCIKES	SH3TC2	1016	Q8TF17
RSRSRKISALKACRI	SPATA31E1	111	Q6ZUB1
RVTSHSLSCRRKGIL	NUAK1	511	O60285
PLRKAKRARLCSSSS	ZC3HC1	396	Q86WB0
AVCRKKFVSSIRLRT	ZFAT	461	Q9P243
SVCSKSFNRRESLKR	ZNF865	381	P0CJ78
FIGKVRRTRKKESSC	SRFBP1	286	Q8NEF9
TKDILRKCATSQGVR	MTHFSD	106	Q2M296
KRLREKSCLIVATTS	UBR1	986	Q8IWV7
ALSKSKSNIERTCRT	MYH13	1241	Q9UKX3
SEEVRSRCSLKHRKS	NF1	2446	P21359
STRSSAKTLKNRPCL	MAPT	396	P10636
KIRLSRLFRTKSCNG	SOCS7	211	O14512
VREKLGSSCKISRDR	THUMPD3	56	Q9BV44
KECGKAFRISSSLRR	ZNF442	436	Q9H7R0
RIKTIKTSCGNITRT	ZNF687	331	Q8N1G0
IKDINTGRSCAVRSK	ZNF766	86	Q5HY98
RKKLTSSGCIDDATR	PPIP5K2	1086	O43314
KECRKAFSVSSSLRR	ZNF891	491	A8MT65
RKGQKRLVLSESCSR	ZMYM3	1036	Q14202
LRKQCTRVTTLTGKK	DUSP19	16	Q8WTR2